Abstract
Abstract
Introduction
Competency-based education has been commonly used to enhance the healthcare workforce for some time. A translational discipline that is integral to drug development and impactful on healthcare and public health is clinical pharmacology. With such contribution, it is essential that the clinical pharmacology workforce is adequately equipped to address the demands of emerging trends of drug development.
Objectives
The primary objective of this study was to determine the most significant competencies needed for a clinical pharmacologist in the regulatory environment.
Methods
A two round modified Delphi technique was administered to 29 clinical pharmacologists within the Office of Clinical Pharmacology (OCP) between November 2021–January 2022.
A questionnaire consisting of core and technical competencies was administered electronically using SurveyMonkey ® to gain consensus about essential clinical pharmacology competencies. Participants used a Likert scale to rank importance of competencies from strongly agree (1), agree (2), neutral (3), disagree (4), strongly disagree (5). Participants also suggested topics to be included in the next round. Consensus was set at 60%. The competencies receiving the most consensus at 60% in round one and the new topics proceeded to the second round. In the second and final round, participants ranked the suggested competencies. Descriptive statistics and a McNemar change test were utilized to analyze data. Only data from the participants who completed both rounds was used in the study.
Results
In round one participants ranked all fifty-six core and technical competencies as essential with consensus of at least 60%. In round two, participants ranked sixty-two competencies as essential with consensus of at least 60%. A McNemar change test demonstrated stability of ranking between rounds.
Conclusion
Essential core and technical competencies can build education programs to sustain the emerging clinical pharmacology workforce in the Office of Clinical Pharmacology. The Delphi technique is a suitable approach to determine essential competencies because it cultivates consensus and gains insight from experts in the forefront of drug development.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference22 articles.
1. Prescription drugs. Health Policy Institute. Published February 13, 2019. Accessed February 27, 2022. https://hpi.georgetown.edu/rxdrugs/
2. Brouwer KLR, Schmidt S, Floren LC, Johnson JA. Clinical pharmacology education - the decade ahead. Clin Pharmacol Ther. 2020;107(1):37–9. https://doi.org/10.1002/cpt.1652.
3. Silva H, Stonier P, Buhler F, et al. Core competencies for pharmaceutical physicians and drug development scientists. Front Pharmacol. 2013. https://doi.org/10.3389/fphar.2013.00105.
4. US Office of Personnel Management launches Federal Workforce Competency Initiative FWCI) to build stronger federal workforce capability [Press release]. Office of Personnel Management. Accessed November 23, 2022. https://www.opm.gov/news/releases/2021/04/release-us-office-of-personnel-management-launches-federal-workforce-competency-initiative-fwci-to-build-stronger-federal-workforce-capability/. Published April 9, 2021.
5. Zineh I, Hartman D. What’s past is prologue: clinical pharmacology at the intersection of science, policy, and patients. Clin Pharmacol Ther. 2020;107(1):33–6. https://doi.org/10.1002/cpt.1650.